Manager, Investor Relations – Corporate Communications

Emploi pas sur LinkedIn

🕒 il y a 2 mois

🇺🇸 États-Unis – Télétravail

⏰ Temps Plein

🟠 Senior

🔴 Expert

🗣️ Communication

👻 Score fantôme 18%

Ce que ça veut dire : la probabilité que cette offre reste ouverte sans recrutement actif.Comment le lire : 60 % ou plus, on pense que c'est une offre fantôme. Un score plus bas est moins inquiétant.Comment on la calcule : ancienneté, republications, postes ouverts vs taille de l'équipe, rapidité de clôture, et si le salaire est indiqué.À noter : une estimation à partir de données publiques, pas un jugement sur l'entreprise. De vraies offres peuvent avoir un score élevé, alors prenez-le comme un indice, pas comme un fait.

Postuler Maintenant

Trouver des Emplois à Distance Similaires

Configurer une alerte email pour les nouveaux emplois

📊 Vérifiez votre score de CV pour ce poste

Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

Télécharger le CV

Iovance Biotherapeutics, Inc.

Site WebLinkedInTous les Emplois

501 - 1000 employés

Fondée en 2014

🏥 Santé

🧬 Biotechnologie

💊 Pharmaceutique

Healthcare • Biotechnology • Pharmaceuticals

Iovance Biotherapeutics, Inc. est à la pointe d'une approche révolutionnaire pour traiter le cancer en exploitant la capacité du système immunitaire humain à reconnaître et attaquer diverses cellules cancéreuses chez chaque patient. La société se concentre sur l'immunothérapie basée sur les cellules T, plus précisément sur la thérapie des lymphocytes infiltrant les tumeurs (TIL), qui consiste à revitaliser les TIL d'un patient pour lutter contre le cancer. La thérapie TIL d'Iovance fait l'objet d'essais cliniques sur plusieurs cancers à tumeurs solides avancées. De plus, l'entreprise développe des thérapies TIL génétiquement modifiées et explore les applications potentielles de la thérapie par lymphocytes du sang périphérique (PBL) pour les cancers du sang. En tant que leader de la thérapie cellulaire, Iovance possède un centre de thérapie cellulaire de pointe à Philadelphie pour la fabrication de leurs thérapies en utilisant un GMP propriétaire. L'entreprise est à l'avant-garde du développement de traitements contre le cancer, personnalisés et spécifiques à chaque patient.

Description

• Create and maintain high-impact investor relations and corporate communications materials, including press releases, earnings scripts, Q&A documents, corporate presentations, FAQs, fact sheets, executive biographies, website content, investor decks, templates, and social media content. • Drive internal reviews, approvals, and final deliverables on behalf of the IR and corporate communications team. • Support analyst and institutional investor engagement and help advance investor targeting strategies. • Monitor metrics and analytics for multi-channel external engagement, media coverage, share of voice, company reputation, market activity, analyst sentiment, peer performance, and consensus estimates, to deliver real-time insights for leadership. • Translate key milestones, including earnings, financings, clinical updates, and business developments, into timely, consistent communications for employees, investors, media, and other stakeholders. • Own logistics, timelines, briefing materials, and execution support for events led by the team, including internal town halls, media interviews/roundtables and investor days. • Support media relations by preparing press materials, tracking coverage, and helping build productive relationships with traditional and social media outlets. • Manage agencies and vendors to keep projects moving, on budget, and aligned with investor relations and corporate communications priorities. • Partner with Finance, Legal, Commercial, R&D, Patient Advocacy, and other teams to deliver accurate, consistent, and compliant communications across filings, disclosures, investor materials, the corporate website, internal meetings, and social media. • Improve processes, tools, and workflows to increase the speed, organization, and scalability of the investor relations and corporate communications function. • Lead or support priority investor relations and communications projects as business needs evolve.

🎯 Exigences

• 8+ years of experience in investor relations, external and internal corporate communications, public relations, equity research, investment banking, corporate finance, healthcare communications, or related fields. • Bachelor’s degree required, preferably in Communications, Public Relations, Journalism, Business, Finance, Marketing, Life Sciences, or a related field. • Experience within biotechnology, pharmaceutical, healthcare, agency, or public company environments strongly preferred. • Working knowledge of capital markets, valuation, investor behavior, sell-side research, SEC disclosure requirements, Regulation FD, and public company investor relations practices. • Strong financial and analytical skills, with the ability to turn clinical, scientific, and financial information into clear investment messaging. • Excellent writer and communicator with experience developing persuasive scripts, presentations, executive materials, and stakeholder communications. • Highly organized project manager who can manage multiple priorities, timelines, and stakeholders with speed, accuracy, and attention to detail. • Strong relationship builder with executive presence, sound judgment, and the ability to influence without authority. • Advanced proficiency in PowerPoint, Excel, Outlook, OneDrive, and SharePoint; experience with FactSet, Bloomberg, HubSpot, WordPress, or market-monitoring platforms is a plus. • Professional maturity, discretion, and sound judgment in handling confidential information. • Proactive self-starter who takes ownership, solves problems, and moves work forward with urgency and curiosity.

🏖️ Avantages

• Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.